News Headlines Article

Lawmakers challenge Turing executives on drug price hikes
Modern Healthcare

The former top lawyer for Turing Pharmaceuticals said Thursday that he and other executives warned Martin Shkreli against the drastic price hike that triggered a national backlash against the company and its 32-year-old former CEO.

The Senate Committee on Aging subpoenaed current and former Turing executives to appear Thursday and explain the fiftyfold price hike of Daraprim, a drug used to treat a life-threatening parasitic infection. Lawmakers struggled to describe the company’s behavior, which Sen. Bob Casey (D-Pa.) called “pure evil.”